These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 12680218)
1. The effect of commonly used drugs on angiogenesis. Sartippour MR; De Leon E; Rubio R; Brooks MN Anticancer Res; 2003; 23(1A):231-4. PubMed ID: 12680218 [TBL] [Abstract][Full Text] [Related]
3. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977 [TBL] [Abstract][Full Text] [Related]
6. Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Huang SS; Zheng RL Cancer Lett; 2006 Aug; 239(2):271-80. PubMed ID: 16239062 [TBL] [Abstract][Full Text] [Related]
7. Novel function of ascorbic acid as an angiostatic factor. Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494 [TBL] [Abstract][Full Text] [Related]
8. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Xiao D; Singh SV Cancer Res; 2007 Mar; 67(5):2239-46. PubMed ID: 17332354 [TBL] [Abstract][Full Text] [Related]
9. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465 [TBL] [Abstract][Full Text] [Related]
10. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823 [TBL] [Abstract][Full Text] [Related]
11. Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells. Liu S; Wu P; Ye D; Huang Y; Zhou X; Li Y; Cai L Pharmacology; 2009; 84(1):17-23. PubMed ID: 19478549 [TBL] [Abstract][Full Text] [Related]
12. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo. Ueda Y; Yamagishi T; Ikeya H; Hirayama N; Itokawa T; Aozuka Y; Samata K; Nakaike S; Tanaka M; Ono M; Saiki I Anticancer Res; 2004; 24(5A):3009-17. PubMed ID: 15517909 [TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis--new drugs on the block. Brower V Nat Biotechnol; 1999 Oct; 17(10):963-8. PubMed ID: 10504695 [No Abstract] [Full Text] [Related]
14. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971 [TBL] [Abstract][Full Text] [Related]
15. [Novobiocin inhibits angiogenesis and shows synergistic effect with vincristine]. Yang J; Jiang M; Zhen YS Yao Xue Xue Bao; 2003 Oct; 38(10):731-4. PubMed ID: 14730893 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of the inhibitory effect of KS-5 on bFGF-induced angiogenesis in vitro and in vivo. Peng CY; Pan SL; Lee KH; Bastow KF; Teng CM Cancer Lett; 2008 May; 263(1):114-21. PubMed ID: 18243528 [TBL] [Abstract][Full Text] [Related]
18. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
19. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. He GA; Luo JX; Zhang TY; Hu ZS; Wang FY Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609 [TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic activity of conjugated linoleic acid on basic fibroblast growth factor-induced angiogenesis. Moon EJ; Lee YM; Kim KW Oncol Rep; 2003; 10(3):617-21. PubMed ID: 12684633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]